GFP Reporter Cell Line - HUVEC

Human umbilical vein endothelial cells (HUVECs) are primary cells isolated from the umbilical vein of human newborns. Due to their ability to mimic the physiological characteristics of endothelial cells in vivo, they are widely used in vascular biology research. HUVECs play a crucial role in studying angiogenesis, inflammation, thrombosis, and vascular permeability. They express typical endothelial cell markers such as CD31, von Willebrand factor, and VE-cadherin, making them valuable for studying cell adhesion, signal transduction, and barrier function. Researchers utilize HUVECs to explore cellular responses to cytokines, growth factors, and shear stress, as well as to model vascular diseases and test potential therapeutic drugs.

The GFP reporter cell line – HUVECs are genetically engineered to express green fluorescent protein (GFP), allowing for real-time tracking and visualization of cellular processes. This modification enables researchers to monitor the dynamic changes of living cells without the use of invasive staining techniques, including cell migration, proliferation, and tube formation in angiogenesis experiments. The GFP reporter system facilitates high-throughput screening of compounds affecting endothelial cell function, such as anti-angiogenic drugs or inflammatory modulators. In co-culture experiments, GFP-labeled HUVECs can be distinguished from other cell types, simplifying the study of cell-cell interactions in the tumor microenvironment or stem cell niche. Furthermore, this cell line supports advanced imaging techniques such as time-lapse microscopy and flow cytometry, providing quantitative data on gene expression or protein localization in response to stimuli such as hypoxia or shear stress. Therefore, the GFP reporter cell line – HUVECs is a powerful tool for accelerating drug discovery and unraveling the molecular mechanisms of vascular biology.